127 related articles for article (PubMed ID: 8292724)
1. Intrinsic procoagulant surface induced by hypercholesterolaemia on rabbit aortic endothelium.
Lupu F; Moldovan N; Ryan J; Stern D; Simionescu N
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):743-52. PubMed ID: 8292724
[TBL] [Abstract][Full Text] [Related]
2. A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin.
Stern DM; Nawroth PP; Kisiel W; Handley D; Drillings M; Bartos J
J Clin Invest; 1984 Dec; 74(6):1910-21. PubMed ID: 6439737
[TBL] [Abstract][Full Text] [Related]
3. A pathway of coagulation on endothelial cells.
Nawroth PP; Stern DM
J Cell Biochem; 1985; 28(4):253-64. PubMed ID: 3877062
[TBL] [Abstract][Full Text] [Related]
4. Assembly of the intrinsic factor X activating complex--interactions between factor IXa, factor VIIIa and phospholipid.
van Dieijen G; van Rijn JL; Govers-Riemslag JW; Hemker HC; Rosing J
Thromb Haemost; 1985 Jun; 53(3):396-400. PubMed ID: 3931288
[TBL] [Abstract][Full Text] [Related]
5. Formation of factor Va by atherosclerotic rabbit aorta mediates factor Xa-catalyzed prothrombin activation.
Rodgers GM; Kane WH; Pitas RE
J Clin Invest; 1988 Jun; 81(6):1911-9. PubMed ID: 3164315
[TBL] [Abstract][Full Text] [Related]
6. Annexin V inhibition of factor IXa-catalyzed factor X activation on human platelets and on negatively-charged phospholipid vesicles.
London F; Ahmad SS; Walsh PN
Biochemistry; 1996 Dec; 35(51):16886-97. PubMed ID: 8988028
[TBL] [Abstract][Full Text] [Related]
7. The functional defect of factor VIII Leiden, a genetic variant of coagulation factor VIII.
Mertens K; van Wijngaarden A; Bertina RM; Veltkamp JJ
Thromb Haemost; 1985 Oct; 54(3):650-3. PubMed ID: 3937262
[TBL] [Abstract][Full Text] [Related]
8. [Blood coagulation mechanism from the viewpoint of molecular biochemistry: Activation of coagulation in phospholipid phase].
Suzuki K
Rinsho Byori; 1985 Sep; 33(9):966-73. PubMed ID: 3878417
[No Abstract] [Full Text] [Related]
9. Regulation of factor IXa in vitro in human and mouse plasma and in vivo in the mouse. Role of the endothelium and the plasma proteinase inhibitors.
Fuchs HE; Trapp HG; Griffith MJ; Roberts HR; Pizzo SV
J Clin Invest; 1984 Jun; 73(6):1696-703. PubMed ID: 6202716
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulant mechanism of factor IX/factor X-binding protein isolated from the venom of Trimeresurus flavoviridis.
Ishikawa M; Kumashiro M; Yamazaki Y; Atoda H; Morita T
J Biochem; 2009 Jan; 145(1):123-8. PubMed ID: 18977769
[TBL] [Abstract][Full Text] [Related]
11. Factor X.
Jackson CM
Prog Hemost Thromb; 1984; 7():55-109. PubMed ID: 6397768
[No Abstract] [Full Text] [Related]
12. Coagulation factor IX residues G4-Q11 mediate its interaction with a shared factor IX/IXa binding site on activated platelets but not the assembly of the functional factor X activating complex.
Ahmad SS; Wong MY; Rawala R; Jameson BA; Walsh PN
Biochemistry; 1998 Feb; 37(6):1671-9. PubMed ID: 9484238
[TBL] [Abstract][Full Text] [Related]
13. Human umbilical vein endothelial cells express high affinity receptors for factor Xa.
Bono F; Herault JP; Avril C; Schaeffer P; Lormeau JC; Herbert JM
J Cell Physiol; 1997 Jul; 172(1):36-43. PubMed ID: 9207923
[TBL] [Abstract][Full Text] [Related]
14. von Willebrand factor as a regulator of intrinsic factor X activation.
Koppelman SJ; Koedam JA; van Wijnen M; Stern DM; Nawroth PP; Sixma JJ; Bouma BN
J Lab Clin Med; 1994 Apr; 123(4):585-93. PubMed ID: 8145007
[TBL] [Abstract][Full Text] [Related]
15. Increased exposure of anionic phospholipids on the surface of tumor blood vessels.
Ran S; Downes A; Thorpe PE
Cancer Res; 2002 Nov; 62(21):6132-40. PubMed ID: 12414638
[TBL] [Abstract][Full Text] [Related]
16. Characterization of an ideal amphipathic peptide as a procoagulant agent.
Ganopolsky JG; Charbonneau S; Peng HT; Shek PN; Blostein MD
Biochem J; 2008 Jun; 412(3):545-51. PubMed ID: 18336367
[TBL] [Abstract][Full Text] [Related]
17. [Activation of factors IX and X by factor VIIa].
Komiyama Y
Rinsho Byori; 1992 Mar; Suppl 92():73-82. PubMed ID: 1583779
[No Abstract] [Full Text] [Related]
18. Effector protease receptor 1 mediates the mitogenic activity of factor Xa for vascular smooth muscle cells in vitro and in vivo.
Herbert J; Bono F; Herault J; Avril C; Dol F; Mares A; Schaeffer P
J Clin Invest; 1998 Mar; 101(5):993-1000. PubMed ID: 9486969
[TBL] [Abstract][Full Text] [Related]
19. Role of accessory components in the activation of vitamin K-dependent coagulation factors.
van Rijn JL; Zwaal RF; Hemker HC; Rosing J
Haemostasis; 1986; 16(3-4):216-26. PubMed ID: 3093336
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms in blood coagulation.
Davie EW; Kirby EP
Curr Top Cell Regul; 1973; 7():51-86. PubMed ID: 4592483
[No Abstract] [Full Text] [Related]
[Next] [New Search]
